About Elveflow
Elveflow is a company based in Paris (France) founded in 2011 by Guilhem Velve Casquillas. Elveflow offers products and services including OB1 Flow Controller and MFS Standard Flow Sensors. Elveflow operates in a competitive market with competitors including Lunaphore, Parallel Fluidics, CellFE, Lightcast Discovery and Sarcura, among others.
- Headquarter Paris, France
- Founders Guilhem Velve Casquillas
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website elveflow.com
- Social LinkedIn X Facebook YouTube
- Legal Name Elvesys
- Latest Funding Round$611.97K (USD), Grant
Nov 2021
- Investors
Products & Services of Elveflow
Elveflow offers a comprehensive portfolio of products and services, including OB1 Flow Controller and MFS Standard Flow Sensors.
Device for precise pressure and flow control in microfluidic experiments.
Sensors for accurate flow measurement in microfluidic applications.
Apps and channels of Elveflow
its YouTube channel Elveflow Microfluidics has 2.06K subscribers and 30 videos.
Videos from Elveflow
The most watched videos on Elveflow's YouTube channel, Elveflow Microfluidics (2.06K subscribers). Click a video to play it here.
More on Elveflow Microfluidics.
Funding Insights of Elveflow
- Total Rounds 11
- Last Round Grant — $611,971
- First Round $48,870
(Jan 2016)
- Investors Count 1
Latest 10 of 11 funding rounds of Elveflow with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2021 | $611,971 | Grant | – | – | |
| Oct 2021 | $548,697 | Grant | – | – | |
| Mar 2020 | $303,714 | Grant | – | – | |
| Feb 2020 | $213,182 | Grant | – | – | |
| Jan 2020 | $339,874 | Grant | – | – | |
| Dec 2019 | $374,763 | Grant | – | – | |
| Oct 2019 | $217,146 | Grant | – | – | |
| Sep 2019 | $604,101 | Grant | – | – | |
| Jul 2019 | $208,482 | Grant | – | – | |
| Apr 2019 | $219,391 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Elveflow
Elveflow has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for Elveflow
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Elveflow
2 people are tracked at Elveflow (2 in leadership).
| Name | Role | Group |
|---|---|---|
Guilhem Velve Casquillas | Founder & Advisor | Leadership |
Eric Farin | CEO | Leadership |
Complete people profiles for Elveflow
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Elveflow
3 dated milestones of Elveflow across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Elveflow is founded.
- Funding First funding round of $49K.
- Funding Latest funding round, Grant, of $612K.
Competitors of Elveflow
Elveflow operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lunaphore, Parallel Fluidics, CellFE, Lightcast Discovery and Sarcura, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lunaphore.com | 2014 | Morges, Switzerland | $82.74M | – | Microfluidic-based instruments for tumor analysis are developed. | |
| parallelfluidics.com | 2020 | Boston, United States | $13.97M | – | Microfluidic chips are provided for research labs using embossing technology. | |
| cellfebiotech.com | 2018 | Berkeley, United States | $26.8M | – | Intracellular gene delivery platform is developed using microfluidic devices. | |
| lightcast.bio | 2019 | Cambridge, United Kingdom | $107.09M | 25 | Advanced single-cell analysis solutions are provided for biotechnology research. | |
| sarcura.com | 2019 | Sankt Andra Wordern, Austria | $10.24M | – | Cell therapy solutions for multiple therapeutic areas are developed. | |
| psidcorp.com | 2001 | Delray Beach, United States | $10.88M | – | Develops diagnostic tools for biological threats and healthcare using advanced PCR technology. | |
| redbudlabs.com | 2010 | Chapel Hill, United States | $304,995 | 20 | Microfluidic platforms for biosensing and sample processing are manufactured. | |
| fluicell.com | 2012 | Gothenburg, Sweden | – | – | Microfluidic devices for single-cell experiments in life sciences are developed. | |
| hummingbirdnano.com | 2012 | Lexington, United States | $2.38M | – | Manufacturer of microfluidic chips |
Detailed competitors of Elveflow
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Elveflow
The website of Elveflow (elveflow.com) receives about 73.2K visits a month.
- Monthly visits73.2K
▲ 9.1% vs previous month
Websites whose visitors overlap most with Elveflow. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| fluigent.com | 100% | 29.1K | #959,472 | View details | |
dolomite-microfluidics.com | dolomite-microfluidics.com | 78% | – | – | – |
| ufluidix.com | 77% | – | #2,325,139 | View details | |
harrickplasma.com | harrickplasma.com | 76% | – | #5,049,627 | – |
syringepump.com | syringepump.com | 70% | – | #2,195,835 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 37 similar websites and full traffic analytics for Elveflow
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 37 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Elveflow
Complete news archive for Elveflow
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Elveflow
10 companies that operate in the same segment as Elveflow (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Elveflow
Elveflow was founded in 2011 and raised its 1st funding round 5 years after it was founded.
Elveflow is headquartered in Paris, France.
Eric Farin is the current CEO of Elveflow.
Elveflow was founded in 2011 in Paris, France, where flow control systems for microfluidic applications are developed and provided. Operations focus on engineering solutions for research and industrial uses, including pressure and syringe pump technologies. Leadership is held by Guilhem Velve Casquillas as founder and advisor, with Eric Farin serving as CEO. The company operates within the scientific instrumentation sector, serving global clients from its European base.
Elveflow's top competitors include CellFE, Parallel Fluidics and Lightcast Discovery.
Elveflow offers OB1 Flow Controller and MFS Standard Flow Sensors.
Elveflow has 1 investor. Key investors include European Union.
Elveflow operates through Elvesys.